Hiroto Tamura

Hiroto Tamura currently serves as Chief Operating Officer and Director of Business Development at Metagen Therapeutics, Inc., focusing on microbiome therapeutics and regulatory affairs since November 2021. Prior experience includes roles in business development aimed at implementing fecal microbiota transplantation for ulcerative colitis in Japan and new business development in the iron 3D printing industry at Nikon. Hiroto has also contributed to research strategy, material development for photon counting optics, and basic research on super hydrophobic surfaces. Education credentials include a Master’s Degree in Mechano-informatics from The University of Tokyo and a Master’s Degree in Management of Technology from Tokyo Institute of Technology, with a focus on entrepreneurship, innovation, and healthcare.